Reporter
-
September 23, 2016
Blood exposures for traditional healers
Traditional healers in sub-Saharan have a high rate of exposure to blood, putting them at risk for HIV and hepatitis C. -
September 22, 2016
Transplant Center experiences strong growth in volume
The Vanderbilt Transplant Center, one of the largest organ transplant programs in the Southeast, has not only surpassed the projected number of transplants it expected to perform for fiscal year (FY) 2016, but also experienced an increase in the total number of transplants performed over the previous year. -
September 22, 2016
EpicLeap mobile information centers begin making rounds
Under the sweeping technology initiative called EpicLeap, Vanderbilt University Medical Center is on course to replace the greater part of its clinical, billing and administrative software by November 2017, with an eye to improving continuity of care, efficiency and patient and care-team experiences. -
September 22, 2016
Star power
The Nashville Predators’ newest star, P.K. Subban, visited with patients and families at Monroe Carell Jr. Children’s Hospital at Vanderbilt on Tuesday. -
September 22, 2016
New prostate cancer therapy investigated at VUMC
Vanderbilt University Medical Center is the world’s first site to treat a patient in the TULSA-PRO Ablation Clinical Trial (TACT), which employs an emerging therapy that uses MRI guidance and robotically driven therapeutic ultrasound to obtain precise prostate cancer tissue ablation. -
September 22, 2016
VUMC’s Lehman lands LUNGevity research support
Jonathan Lehman, M.D., Ph.D., instructor in Medicine in the Division of Hematology/Oncology, has received a Career Development Award from LUNGevity, a nonprofit organization that provides support programs for lung cancer patients and families, public education and funding for innovative scientific research. -
September 22, 2016
National Lymphedema Network honors VUMC research efforts
Lymphedema research conducted at Vanderbilt University Medical Center (VUMC) to better understand patient risk for this chronic condition and treatment responses received recognition at an international conference.